Notice of Results
M&A and growth expertise will benefit Sopheon’s strategic goals
Sopheon, the global leader in Innovation Management software and expertise, is delighted to announce the addition of Barnaby (Barney) Kent as an Independent Non-Executive Director of Sopheon’s Board of Directors. Barney becomes the seventh Sopheon Board member and the fourth Non-Executive Director. Dedicated to ensuring financial strength alongside growth objectives, Sopheon’s board encompasses a range of experiences and provides the independent judgment necessary to maintain high standards of corporate governance.
Prior to its recent $1.3 billion acquisition by a London-based private equity firm in 2022, Barney spent nearly a decade at publicly held Ideagen plc (formerly LSE: IDEA) a software company supplying regulatory, compliance and collaboration solutions to over 10,000 organizations around the world. In his role as COO, he led Ideagen to unprecedented growth and financial delivery. Barney has more than 20 years’ experience within the technology sector and was previously CEO of Plumtree Group prior to joining Ideagen. He has a BSc (Hons) from the University of Southampton and an MBA from Edinburgh Business School.
Barney Kent’s addition to the Board further positions Sopheon to execute its mission to empower organizations to change the world,” said Greg Coticchia, Chief Executive Officer of Sopheon. “His expertise in expanding organizations via both organic growth and M&A activities is aligned with Sopheon’s business growth goals, specifically as we continue to increase revenue in the SaaS market and look for strategic acquisition opportunities. Barney’s experience and insight will be a valuable addition to the Board as it guides Sopheon toward continued growth.
Joining the Sopheon Board represents an exciting opportunity to assist an already thriving organization to maximize its value,” said Barney Kent. “The company’s historically strong performance, coupled with its ability to maintain positive bottom-line results while transitioning to an expanding SaaS based model, shows a deep commitment to customers and investors alike. I look forward to using my experience and skills to further Sopheon’s position as a market leader in the Innovation Management market.
Notice of Results
A comprehensive update and review of the year will be provided with the Company's annual results for the year ended 31 December 2022, which are expected to be announced on 23 March 2023.
For further information contact:
| Andy Michuda, (Executive Chairman) Arif Karimjee, (CFO) |
Sopheon plc | + 44 (0) 1276 919 560 |
| Carl Holmes/Abigail Kelly/George Dollemore (Corporate Finance) Alice Lane/Sunila da Silva (ECM) |
finnCap | + 44 (0) 20 7220 0500 |
Sopheon®, Accolade® and Acclaim™ are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.
About Sopheon
Sopheon (LSE: SPE) empowers organizations to change the world while achieving exceptional long-term revenue growth and profitability. By operationalizing the entire innovation life cycle, Accolade® and Acclaim™ software and expertise enable innovation, product and project professionals to accomplish the full range of InnovationOps tasks to drive innovation at scale. Sopheon’s industry leadership was highlighted in the comprehensive MarketsandMarkets™ report on the Innovation Management market, in which Sopheon was listed in the “Stars” category, the highest recognition. Sopheon’s solutions have been implemented by hundreds of blue-chip customers with over 125,000 users in 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange.
Regulatory disclosures
The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Barnaby (Barney) Luke Kent, aged 47:
Current Directorships
Equals Trust Ltd
Plumtree Consultants Ltd
Directorships within the past five years
Ideagen Limited
Ideagen Gael Limited
Ideagen Optima Diagnostics Limited
Ideagen Redland Business Solutions Limited
Ideagen Software Limited
Ideagen Technology Limited
Ideagen Workrite Limited
Qualsys Limited
Kempson Rose LLP
Sopheon confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Barnaby Kent.